Cohance Lifesciences shares surged 20% on Monday after appointing former Cipla CEO Umang Vohra as Executive Chairman and Group CEO. The company expects his leadership to push transformation, expand operations, and deepen global partnerships as it moves into a new growth phase. Investors reacted sharply to the change at the top.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
